Effect of duration of use of hormonal contraceptive pills on total lipid and lipoproteins in Nigerian womens

International Journal of Pharma and Bio Sciences

Volumn 1, Issue 3, 2010, Pages

  Emokpae, M A ^a   Uadia, P O ^a   Osadolor, H B ^a  

^a UNIVERSITY OF BENIN   (Nigeria)

Author keywords

Lipid; Lipoprotein; Oral contraceptive pills

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL CONTRACEPTIVE AGENT; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; COLORIMETRY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; FEMALE; HORMONAL CONTRACEPTION; HORMONAL REGULATION; HORMONE ACTION; HUMAN; LIPID BLOOD LEVEL; LIPID PEROXIDATION; NIGERIA; OUTCOME ASSESSMENT; SYSTOLIC BLOOD PRESSURE; WOMEN'S HEALTH;

EID: 84455204125     PISSN: None     EISSN: 09756299     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. WHO collaborative study of Cardiovascular Disease and steroid Hormone contraception. Venous thromboembolic disease and combined Oral contraceptive: results of international multicentre case-control study. Lancet 1995; 346:1575-1582.
2. Wynn V, Doar JWH and Mills GL. Some effects of Oral contraceptives on some lipids and lipoprotein levels. Lancet 1966; ii:720.
3. Osman MM, Toppozado HK, Ghanem MK and Guergir FK. Effect of contraceptive steroids on serum lipids. AM J Obstet Gynecol 1972; 123:736-741.
4. Uadia PO, Famodu AA and Emokpae MA. Effect of Oral contraceptive pills on some serum lipid and electrolyte levels in women with haemoglobin genotypes AA and AS. Med Sci Res 2000; 28: 9-11.
5. Syed S and Qureshi MA. Effects of hormonal contraception on plasma lipid and lipoprotein cholesterol concentrations. J Coll Physicians Surg Pak 2002; 12(10):593-598.
6. Sagay AS, Okeahialam BM, Imade GE, Aishien AO. Evaluation of cardiovascular morbidity in Nigerian women after 3 years of Norplant contraception. Afr Reprod Health 2008;12(1):47-53.
7. Friedwald WT, Levy RT and Frederickson DS. Estimation of concentrations of low density lipoprotein cholesterol in plasma without use of preparative centrifuge. Clin Chem 1972;18:499-502.
8. Zollner N and Kirsch K. Colourimetric estimation of total lipid in biological systems. Ges Exp Med 1962; 135:546-548.
9. The ESHRE Capri workshop Group. Screening before and during the use of oral contraceptives and hormone replacement therapy. Human Reprod 2000;15(12):485-492.
10. World Health Organization study of cardiovascular disease and steroid hormone contraception. A multinational case-control study of a cardiovascular disease and steroid hormone contraceptives. Description and validation of methods. J Clin Epidemiol 1995;48:1513-1547.
11. WHO collaborative study of cardiovascular disease and steroid hormone contraception. Ischaemic stroke and combined oral contraceptives: results of an international multicentre case-control study. Lancet 1996;348:498-505.
12. Mia AR, Siddiqui NI, Islam MN, Khan MR, Shampa SS, Rukunuzzaman M. Effects of prolonged use of injectable hormonal contraceptive on serum lipid profile. Mymensingh Med J 2005;14(1):19-21.
13. Gundoff H. Clinical relevance of oral contraceptive pill induced plasma lipid changes; facts and fiction. Am J Obstet Gynecol 1990; 134:790-795.
14. Wallace RB, Tamir I, Heiss G, Rifkind BM, Christensen B and Glueck CJ. Plasma lipids, lipoproteins and blood pressure in female adolescents using oral contraceptives. J pediat 1979;95:1055-1059.
15. Thorogood M and Vessey MP. Trends in use of oral contraceptives in Britain. Br J Family Plan 1990; 16: 41-53.
16. th ed in: Katzung BG (ed) Appleton and Lange publishers, Connecticut, USA. 2001, p.679-708.
17. Soska V, Fiala J, Nebeska K, Hruba D. Secondary Dyslipidaemia after Oral contraceptives. Vnitr Lek 2009; 55(10):929-933.
18. Duvillard L, Dantin G, Florentin E et al. Increased apolipoprotein A1 production rate and redistribution of high density lipoprotein size induced by estrogen plus progestin as Oral contraceptive. J Clin Endocrinol Metab 2009; 94(12):4891-4897.
19. Nessa A, Latif SA, Uddin MM, Hussain MA. Serum HDL cholesterol in women using low dose Oral contraceptives. Mymensingh Med J 2007;16(2suppl):S3-6.
20. Szlendak-Saner K, Radowick S, Skorzewska K. The impact of a new low dose Oral contraceptive containing drospirenone on lipid profile, carbohydrate metabolism and hepatic function. Ginekol Pol 2009;80(2):99-102.
21. Shivaprakash TM, Purnima DS, Tripti S, Ramprasad N, Mahesh-Wari R. Oxidative stress and Paraoxonase status for coronary Artery Disease in NIDDM patients. Biomedical Res 2006;18(1):19-23.